<div>In what is being hailed as a cancer treatment breakthrough, three men suffering late-stage leukemia were cured in just three weeks after being treated with genetically engineered versions of their own immune cells.
The findings are the first demonstration of the use of gene transfer therapy to create T cells aimed at cancerous tumours.
More...
The findings are the first demonstration of the use of gene transfer therapy to create T cells aimed at cancerous tumours.
More...